Rafarma Pharmaceuticals Stock Forecast

Sell candidate since Nov 17, 2025

The Rafarma Pharmaceuticals, Inc. stock price fell by -12.62% on the last day (Monday, 17th Nov 2025) from $0.0420 to $0.0367. During the last trading day the stock fluctuated 0% from a day low at $0.0367 to a day high of $0.0367. The price has fallen in 5 of the last 10 days and is down by -0.81% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -46 thousand shares and in total, 1 thousand shares were bought and sold for approximately $37.80 .

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -42.87% during the next 3 months and, with a 90% probability hold a price between $0.0150 and $0.0361 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

RAFA Signals & Forecast

There are mixed signals in the stock today. The Rafarma Pharmaceuticals, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.0395. On a fall, the stock will find some support from the short-term average at $0.0351. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Friday, November 14, 2025, and so far it has fallen -12.62%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Rafarma Pharmaceuticals, Inc. stock

Rafarma Pharmaceuticals, Inc. finds support from accumulated volume at $0.0350 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 5.50%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (RAFA) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Rafarma Pharmaceuticals, Inc. to open at $0.0367, and during the day (based on 14 day Average True Range), to move between $0.0352 and $0.0382, which gives a possible trading interval of +/-$0.0029 (+/-8.36%) up or down from last closing price. If Rafarma Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 8.36% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.0370 (0.82%) than the support at $0.0350 (4.63%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Rafarma Pharmaceuticals, Inc. stock A Buy?

Rafarma Pharmaceuticals, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

Current score: -2.633 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $0.0367 ( 0%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk